Logo image of CLF

CLEVELAND-CLIFFS INC (CLF) Stock Fundamental Analysis

NYSE:CLF - New York Stock Exchange, Inc. - US1858991011 - Common Stock - Currency: USD

8.82  +0.06 (+0.68%)

After market: 8.75 -0.07 (-0.79%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to CLF. CLF was compared to 154 industry peers in the Metals & Mining industry. Both the profitability and financial health of CLF have multiple concerns. While showing a medium growth rate, CLF is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

In the past year CLF has reported negative net income.
CLF had a negative operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: CLF reported negative net income in multiple years.
Of the past 5 years CLF 4 years had a positive operating cash flow.
CLF Yearly Net Income VS EBIT VS OCF VS FCFCLF Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B 4B

1.2 Ratios

CLF has a Return On Assets of -5.67%. This is in the lower half of the industry: CLF underperforms 63.64% of its industry peers.
CLF has a worse Return On Equity (-18.90%) than 67.53% of its industry peers.
Industry RankSector Rank
ROA -5.67%
ROE -18.9%
ROIC N/A
ROA(3y)1.93%
ROA(5y)4.16%
ROE(3y)3.63%
ROE(5y)12.18%
ROIC(3y)N/A
ROIC(5y)N/A
CLF Yearly ROA, ROE, ROICCLF Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 200

1.3 Margins

CLF does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CLF Yearly Profit, Operating, Gross MarginsCLF Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

2

2. Health

2.1 Basic Checks

CLF does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, CLF has less shares outstanding
CLF has more shares outstanding than it did 5 years ago.
The debt/assets ratio for CLF is higher compared to a year ago.
CLF Yearly Shares OutstandingCLF Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M
CLF Yearly Total Debt VS Total AssetsCLF Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B

2.2 Solvency

CLF has an Altman-Z score of 1.13. This is a bad value and indicates that CLF is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.13, CLF is doing worse than 74.68% of the companies in the same industry.
A Debt/Equity ratio of 1.22 is on the high side and indicates that CLF has dependencies on debt financing.
CLF's Debt to Equity ratio of 1.22 is on the low side compared to the rest of the industry. CLF is outperformed by 89.61% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.22
Debt/FCF N/A
Altman-Z 1.13
ROIC/WACCN/A
WACC8.52%
CLF Yearly LT Debt VS Equity VS FCFCLF Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B

2.3 Liquidity

CLF has a Current Ratio of 2.13. This indicates that CLF is financially healthy and has no problem in meeting its short term obligations.
With a Current ratio value of 2.13, CLF perfoms like the industry average, outperforming 46.10% of the companies in the same industry.
A Quick Ratio of 0.64 indicates that CLF may have some problems paying its short term obligations.
With a Quick ratio value of 0.64, CLF is not doing good in the industry: 83.77% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 2.13
Quick Ratio 0.64
CLF Yearly Current Assets VS Current LiabilitesCLF Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

4

3. Growth

3.1 Past

The earnings per share for CLF have decreased strongly by -284.85% in the last year.
Looking at the last year, CLF shows a very negative growth in Revenue. The Revenue has decreased by -15.00% in the last year.
CLF shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 57.33% yearly.
EPS 1Y (TTM)-284.85%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-655.56%
Revenue 1Y (TTM)-15%
Revenue growth 3Y-2.1%
Revenue growth 5Y57.33%
Sales Q2Q%-10.96%

3.2 Future

Based on estimates for the next years, CLF will show a very strong growth in Earnings Per Share. The EPS will grow by 36.61% on average per year.
The Revenue is expected to grow by 1.94% on average over the next years.
EPS Next Y-16.4%
EPS Next 2Y50.44%
EPS Next 3Y36.61%
EPS Next 5YN/A
Revenue Next Year2.4%
Revenue Next 2Y4.25%
Revenue Next 3Y4.64%
Revenue Next 5Y1.94%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
CLF Yearly Revenue VS EstimatesCLF Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 5B 10B 15B 20B
CLF Yearly EPS VS EstimatesCLF Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 2 4

1

4. Valuation

4.1 Price/Earnings Ratio

CLF reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
The Price/Forward Earnings ratio is 26.61, which means the current valuation is very expensive for CLF.
The rest of the industry has a similar Price/Forward Earnings ratio as CLF.
When comparing the Price/Forward Earnings ratio of CLF to the average of the S&P500 Index (21.90), we can say CLF is valued slightly more expensively.
Industry RankSector Rank
PE N/A
Fwd PE 26.61
CLF Price Earnings VS Forward Price EarningsCLF Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80 100

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CLF Per share dataCLF EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

A more expensive valuation may be justified as CLF's earnings are expected to grow with 36.61% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y50.44%
EPS Next 3Y36.61%

0

5. Dividend

5.1 Amount

CLF does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

CLEVELAND-CLIFFS INC

NYSE:CLF (7/3/2025, 7:12:53 PM)

After market: 8.75 -0.07 (-0.79%)

8.82

+0.06 (+0.68%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)05-07 2025-05-07/amc
Earnings (Next)07-21 2025-07-21/amc
Inst Owners74.61%
Inst Owner Change-0.29%
Ins Owners1.64%
Ins Owner Change9%
Market Cap4.36B
Analysts65.56
Price Target9.62 (9.07%)
Short Float %15.4%
Short Ratio2.34
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-38.82%
Min EPS beat(2)-49.04%
Max EPS beat(2)-28.61%
EPS beat(4)1
Avg EPS beat(4)-17.14%
Min EPS beat(4)-90.92%
Max EPS beat(4)100%
EPS beat(8)3
Avg EPS beat(8)-6.5%
EPS beat(12)4
Avg EPS beat(12)-8.8%
EPS beat(16)6
Avg EPS beat(16)-8.33%
Revenue beat(2)0
Avg Revenue beat(2)-2.23%
Min Revenue beat(2)-3.31%
Max Revenue beat(2)-1.15%
Revenue beat(4)0
Avg Revenue beat(4)-3.18%
Min Revenue beat(4)-5.15%
Max Revenue beat(4)-1.15%
Revenue beat(8)1
Avg Revenue beat(8)-2.01%
Revenue beat(12)3
Avg Revenue beat(12)-1.71%
Revenue beat(16)5
Avg Revenue beat(16)-0.94%
PT rev (1m)-14.96%
PT rev (3m)-25.44%
EPS NQ rev (1m)-42.05%
EPS NQ rev (3m)-1120.09%
EPS NY rev (1m)-49.09%
EPS NY rev (3m)-219.26%
Revenue NQ rev (1m)-1.21%
Revenue NQ rev (3m)-4.31%
Revenue NY rev (1m)-1.63%
Revenue NY rev (3m)-3.35%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 26.61
P/S 0.23
P/FCF N/A
P/OCF N/A
P/B 0.7
P/tB 1.31
EV/EBITDA N/A
EPS(TTM)-2.44
EYN/A
EPS(NY)0.33
Fwd EY3.76%
FCF(TTM)-2.13
FCFYN/A
OCF(TTM)-0.78
OCFYN/A
SpS37.63
BVpS12.64
TBVpS6.75
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -5.67%
ROE -18.9%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)1.93%
ROA(5y)4.16%
ROE(3y)3.63%
ROE(5y)12.18%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.89
Health
Industry RankSector Rank
Debt/Equity 1.22
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 66.3%
Cap/Sales 3.57%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.13
Quick Ratio 0.64
Altman-Z 1.13
F-Score3
WACC8.52%
ROIC/WACCN/A
Cap/Depr(3y)76.89%
Cap/Depr(5y)95.94%
Cap/Sales(3y)3.55%
Cap/Sales(5y)4.78%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-284.85%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-655.56%
EPS Next Y-16.4%
EPS Next 2Y50.44%
EPS Next 3Y36.61%
EPS Next 5YN/A
Revenue 1Y (TTM)-15%
Revenue growth 3Y-2.1%
Revenue growth 5Y57.33%
Sales Q2Q%-10.96%
Revenue Next Year2.4%
Revenue Next 2Y4.25%
Revenue Next 3Y4.64%
Revenue Next 5Y1.94%
EBIT growth 1Y-223.44%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year271.12%
EBIT Next 3Y82.56%
EBIT Next 5Y47.39%
FCF growth 1Y-210.15%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-120.96%
OCF growth 3Y-66.47%
OCF growth 5Y-28.65%